XML 43 R36.htm IDEA: XBRL DOCUMENT v3.25.1
Promissory Note - Additional Information (Details) - USD ($)
3 Months Ended
Feb. 28, 2025
Mar. 31, 2025
Debt Instrument [Line Items]    
Maturity date Sep. 01, 2028  
Loan Agreement    
Debt Instrument [Line Items]    
Aggregate principal amount $ 32,500,000  
Debt Instrument, Interest Rate, Stated Percentage 12.75%  
Loan Agreement | Prime Rate    
Debt Instrument [Line Items]    
Debt Instrument, Interest Rate, Stated Percentage 5.00%  
Loan Agreement | Avenue Venture Opportunities Fund II, L.P.    
Debt Instrument [Line Items]    
Convertible value of promissory note warrants into common stock $ 1,000,000  
Debt instrument, convertible, terms of conversion   At the closing date, up to $1,000,000 of the principal outstanding may be converted into shares of the Company’s unrestricted, freely tradable common stock at a price equal to 20% premium to the exercise price of the warrants (see note 6 for further description of the warrants) at the Lender’s option. Upon drawing Tranche 2, $1,000,000 will be added to the conversion option for a total of $2,000,000.
Tranche 1 | Loan Agreement    
Debt Instrument [Line Items]    
Aggregate principal amount 10,000,000  
Tranche 2 | Loan Agreement    
Debt Instrument [Line Items]    
Aggregate principal amount $ 7,500,000  
Repayment term The Company will make interest only payments until the 18 month anniversary of the Closing Date, subject to a 6-month extension upon the Company’s achievement of certain milestones with respect to certain of its ongoing clinical trials and funding of the full amount under Tranche 2.  
Tranche 2 | Loan Agreement | Avenue Venture Opportunities Fund II, L.P.    
Debt Instrument [Line Items]    
Aggregate principal amount $ 15,000,000  
Convertible value of promissory note warrants into common stock 2,000,000  
Additional convertible promissory note warrant into commonstock value $ 1,000,000